Your browser doesn't support javascript.
The global response to the COVID-19 pandemic: how have immunology societies contributed?
Osier, Faith; Ting, Jenny P Y; Fraser, John; Lambrecht, Bart N; Romano, Marta; Gazzinelli, Ricardo T; Bortoluci, Karina R; Zamboni, Dario S; Akbar, Arne N; Evans, Jennie; Brown, Doug E; Patel, Kamala D; Wu, Yuzhang; Perez, Ana B; Pérez, Oliver; Kamradt, Thomas; Falk, Christine; Barda-Saad, Mira; Ariel, Amiram; Santoni, Angela; Annunziato, Francesco; Cassatella, Marco A; Kiyono, Hiroshi; Chereshnev, Valeriy; Dieye, Alioune; Mbow, Moustapha; Mbengue, Babacar; Niang, Maguette D S; Suchard, Melinda.
  • Osier F; Biosciences Department, KEMRI Wellcome, Kilifi, Kenya. fosier@kemri-wellcome.org.
  • Ting JPY; Parasitology Department, Heidelberg University Hospital, Heidelberg, Germany. fosier@kemri-wellcome.org.
  • Fraser J; Department of Genetics, Lineberger Comprehensive Cancer Center, University of North Carolina Chapel Hill, Chapel Hill, NC, USA. jenny_ting@med.unc.edu.
  • Lambrecht BN; Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand. j.fraser@auckland.ac.nz.
  • Romano M; VIB-UGent Center for Inflammation Research, Ghent, Belgium. bart.lambrecht@ugent.be.
  • Gazzinelli RT; Sciensano, Brussels, Belgium.
  • Bortoluci KR; Fundação Oswaldo Cruz, Rio de Janeiro, Brazil. ricardo.gazzinelli@fiocruz.br.
  • Zamboni DS; Universidade Federal de São Paulo, São Paulo, Brazil.
  • Akbar AN; Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, São Paulo, Brazil.
  • Evans J; Division of Infection and Immunity, University College London, London, UK. a.akbar@ucl.ac.uk.
  • Brown DE; British Society for Immunology, London, UK.
  • Patel KD; British Society for Immunology, London, UK.
  • Wu Y; Department of Physiology and Pharmacology, University of Calgary, Calgary, AB, Canada. kpatel@ucalgary.ca.
  • Perez AB; Department of Biochemistry and Molecular Biology, University of Calgary, Calgary, AB, Canada. kpatel@ucalgary.ca.
  • Pérez O; Institute of Immunology, Army Medical University, Chongqing, China. wuyuzhang@tmmu.edu.cn.
  • Kamradt T; Pedro Kourí Institute, Havana, Cuba. anab@ipk.sld.cu.
  • Falk C; Instituto de Ciencias Básicas y Preclínicas 'Victoria de Girón', Universidad de Ciencias Médicas de la Habana, Havana, Cuba.
  • Barda-Saad M; Institute of Immunology, Jena, Germany. thomas.kamradt@med.uni-jena.de.
  • Ariel A; DZIF, Hannover Medical School, Hannover, Germany.
  • Santoni A; Laboratory of Molecular and Applied Immunology, The Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat Gan, Israel. mira.barda-saad@biu.ac.il.
  • Annunziato F; Department of Human Biology, Faculty of Natural Sciences, University of Haifa, Haifa, Israel.
  • Cassatella MA; Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy. angela.santoni@uniroma1.it.
  • Kiyono H; Instituto Pasteur Italia, Cenci Bolognetti Foundation, Rome, Italy. angela.santoni@uniroma1.it.
  • Chereshnev V; School of Medicine, University of Florence, Florence, Italy.
  • Dieye A; Flow Cytometry Diagnostic Core, Careggi University Hospital, Florence, Italy.
  • Mbow M; University of Verona, Verona, Italy.
  • Mbengue B; Division of Mucosal Immunology, Institute of Medical Science, University of Tokyo, Tokyo, Japan. kiyono@ims.u-tokyo.ac.jp.
  • Niang MDS; Institute for Global Prominent Research, Graduate School of Medicine, Chiba University, Chiba, Japan. kiyono@ims.u-tokyo.ac.jp.
  • Suchard M; Center for Mucosal Immunology, Allergy and Vaccines, Division of Gastroenterology, Department of Medicine, School of Medicine, University of California, San Diego, San Diego, CA, USA. kiyono@ims.u-tokyo.ac.jp.
Nat Rev Immunol ; 20(10): 594-602, 2020 10.
Artículo en Inglés | MEDLINE | ID: covidwho-759596
ABSTRACT
The COVID-19 pandemic is shining a spotlight on the field of immunology like never before. To appreciate the diverse ways in which immunologists have contributed, Nature Reviews Immunology invited the president of the International Union of Immunological Societies and the presidents of 15 other national immunology societies to discuss how they and their members responded following the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Neumonía Viral / Sociedades Científicas / Infecciones por Coronavirus / Síndrome Respiratorio Agudo Grave / Pandemias / COVID-19 / Cooperación Internacional Tipo de estudio: Estudio observacional Tópicos: Vacunas Límite: Humanos Idioma: Inglés Revista: Nat Rev Immunol Asunto de la revista: Alergia e Inmunología Año: 2020 Tipo del documento: Artículo País de afiliación: S41577-020-00428-4

Similares

MEDLINE
LILACS
LIS
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Neumonía Viral / Sociedades Científicas / Infecciones por Coronavirus / Síndrome Respiratorio Agudo Grave / Pandemias / COVID-19 / Cooperación Internacional Tipo de estudio: Estudio observacional Tópicos: Vacunas Límite: Humanos Idioma: Inglés Revista: Nat Rev Immunol Asunto de la revista: Alergia e Inmunología Año: 2020 Tipo del documento: Artículo País de afiliación: S41577-020-00428-4